Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Albemarle Corp Stock Research

ALB

168.94USD-5.50(-3.15%)Market Closed
Watchlist

Market Summary

USD168.94-5.50
Market Closed
-3.15%

ALB Alerts

ALB Stock Price

ALB RSI Chart

ALB Valuation

Market Cap

20.5B

Price/Earnings (Trailing)

5.22

Price/Sales (Trailing)

2.12

EV/EBITDA

5.55

Price/Free Cashflow

21.24

ALB Price/Sales (Trailing)

ALB Profitability

Operating Margin

44.48%

EBT Margin

37.52%

Return on Equity

39.89%

Return on Assets

20.92%

Free Cashflow Yield

4.71%

ALB Fundamentals

ALB Revenue

Revenue (TTM)

9.7B

Revenue Y/Y

60.19%

Revenue Q/Q

-8.14%

ALB Earnings

Earnings (TTM)

3.9B

Earnings Y/Y

59.8%

Earnings Q/Q

-47.52%

Price Action

52 Week Range

167.70333.39
(Low)(High)

Last 7 days

-5.3%

Last 30 days

-7.2%

Last 90 days

-22.8%

Trailing 12 Months

-39.1%

ALB Financial Health

Current Ratio

1.9

ALB Investor Care

Dividend Yield

0.91%

Dividend/Share (TTM)

1.59

Shares Dilution (1Y)

0.19%

Diluted EPS (TTM)

33.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for ALB

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-07-03
Cramer Ralf Hans
acquired
-
-
750
-
2023-07-03
BRLAS LAURIE
acquired
-
-
750
-
2023-07-03
OBRIEN JAMES J /KY
acquired
-
-
750
-
2023-07-03
OConnell Diarmuid B.
acquired
-
-
750
-
2023-07-03
Seavers Dean
acquired
-
-
750
-
2023-07-03
Wolff Alejandro Daniel
acquired
-
-
750
-
2023-05-10
Norris Eric
bought
246,317
195
1,260
president, energy storage
2023-05-05
Coleman Kristin M.
bought
249,886
182
1,373
evp, general counsel
2023-05-05
Masters J Kent
bought
993,571
181
5,470
chairman & ceo
2023-04-19
Masters J Kent
acquired
-
-
54,475
chairman & ceo

1–10 of 50

Which funds bought or sold ALB recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-18
WASHINGTON CAPITAL MANAGEMENT, INC
unchanged
-
5,627
612,382
0.52%
2023-09-12
Farther Finance Advisors, LLC
added
2.99
2,916
76,743
0.02%
2023-09-07
ST GERMAIN D J CO INC
new
-
167,987
167,987
0.01%
2023-09-05
Covenant Partners, LLC
added
0.89
7,257
404,908
0.15%
2023-09-01
Manhattan West Asset Management, LLC
added
46.25
699,632
2,169,330
0.81%
2023-08-30
Western Wealth Management, LLC
reduced
-6.06
-29,364
539,972
0.05%
2023-08-28
DT Investment Partners, LLC
unchanged
-
3,256
22,047
-%
2023-08-28
DELPHI MANAGEMENT INC /MA/
new
-
1,183,000
1,183,000
1.23%
2023-08-24
Alberta Investment Management Corp
reduced
-1.35
-20,996
4,811,160
0.05%
2023-08-23
Stonebridge Capital Advisors LLC
unchanged
-
1,249
135,862
0.01%

1–10 of 48

Latest Funds Activity

Are funds buying ALB calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ALB
No. of Funds

Schedule 13G FIlings of Albemarle

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
capital international investors
6.7%
7,868,987
SC 13G
Feb 09, 2023
vanguard group inc
12.10%
14,174,413
SC 13G/A
Feb 03, 2023
blackrock inc.
8.0%
9,321,844
SC 13G/A
Feb 09, 2022
vanguard group inc
11.61%
13,585,134
SC 13G/A
Feb 09, 2022
state street corp
4.57%
5,348,397
SC 13G/A
Feb 03, 2022
franklin resources inc
4.2%
4,910,125
SC 13G/A
Feb 01, 2022
blackrock inc.
7.8%
9,121,178
SC 13G/A
Feb 10, 2021
vanguard group inc
11.41%
12,143,615
SC 13G/A
Feb 05, 2021
state street corp
5.27%
5,614,068
SC 13G
Feb 01, 2021
franklin resources inc
5.4%
5,740,155
SC 13G/A

Recent SEC filings of Albemarle

View All Filings
Date Filed Form Type Document
Aug 02, 2023
8-K
Current Report
Aug 02, 2023
10-Q
Quarterly Report
Jul 27, 2023
8-K
Current Report
Jul 06, 2023
4
Insider Trading
Jul 06, 2023
4
Insider Trading
Jul 06, 2023
4
Insider Trading
Jul 06, 2023
4
Insider Trading
Jul 06, 2023
4
Insider Trading
Jul 06, 2023
4
Insider Trading
Jul 06, 2023
4
Insider Trading

Peers (Alternatives to Albemarle)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
34.0B
12.5B
-1.07% 37.74%
7.2
2.71
-3.90% 152.35%
20.5B
9.7B
-7.25% -39.15%
5.22
2.12
123.06% 1386.73%
13.9B
-
8.46% 30.48%
10.98
1.25
22.25% -35.45%
-
17.9B
-5.63% 12.72%
-
-
1.96% 21.57%
MID-CAP
10.0B
9.8B
-5.95% 1.41%
12.61
0.94
-10.03% -41.97%
6.1B
7.8B
-14.24% 6.57%
7.54
0.78
-20.33% -46.41%
4.4B
6.9B
-8.02% -1.27%
22.73
0.64
-19.93% -84.77%
3.3B
3.3B
-0.38% -0.41%
5.78
1.01
-3.65% 128.94%
-
5.1B
-3.30% 12.06%
-
-
9.03% 9.70%
SMALL-CAP
841.7M
1.7B
-8.79% -9.18%
7.56
0.49
-11.49% -43.12%
310.8M
4.1B
-24.91% -62.60%
-0.35
0.08
-23.57% -425.83%
186.2M
1.8B
-5.94% -32.46%
10.31
0.1
21.33% 123.48%

Albemarle News

Best Stocks
Wipro Limited Appoints Aparna C Iyer as New CFO.
Best Stocks,
7 hours ago
InvestorsObserver
InvestorPlace
InvestorPlace

Returns for ALB

Cumulative Returns on ALB

12.2%


10-Year Cumulative Returns

13.1%


7-Year Cumulative Returns

11.9%


5-Year Cumulative Returns

22.0%


3-Year Cumulative Returns

Risks for ALB

What is the probability of a big loss on ALB?

99.6%


Probability that Albemarle stock will be more than 20% underwater in next one year

75.4%


Probability that Albemarle stock will be more than 30% underwater in next one year.

37.7%


Probability that Albemarle stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ALB drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Albemarle was unfortunately bought at previous high price.

Drawdowns

Financials for Albemarle

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue10.2%9,6638,7737,3205,5934,3323,6263,3283,3133,2293,2193,1293,2423,3753,4963,5893,5193,4173,3853,3753,3113,288
Gross Profit-0.6%3,8803,9023,0752,3101,5151,1839981,0271,0321,0179951,0681,1241,2161,2581,2401,2101,1961,2171,2011,196
  S&GA Expenses47.4%834566524499468461441443436421430490502522533469461458446443450
  R&D Expenses5.3%80.0076.0072.0064.0059.0055.0054.0057.0058.0058.0059.0058.0060.0059.0058.0060.0061.0064.0070.0075.0080.00
EBITDA-100.0%-3,6132,7341,8464445683884381,073655639664702776810------
EBITDA Margin-100.0%-0.41*0.37*0.33*0.10*0.16*0.12*0.13*0.33*0.20*0.20*0.20*0.21*0.22*0.23*------
Earnings Before Taxes-7.1%3,0583,2912,4331,562176310134190828381374403446525563614605810795807782
EBT Margin-100.0%-0.38*0.33*0.28*0.04*0.09*0.04*0.06*0.26*0.12*0.12*0.12*0.13*0.15*0.16*------
Net Income6.6%3,9183,6752,6901,554264281124212703364376382438507533572547695694346335
Net Income Margin-100.0%-0.42*0.37*0.28*0.06*0.08*0.04*0.06*0.22*0.11*0.12*0.12*0.13*0.14*0.15*------
Free Cashflow-100.0%-977646-307-1,040-613-609-54.06148-13.82-51.56-29.26-127-30.68-132------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets8.8%19,11017,56415,45713,82912,52011,41610,97410,83210,79710,29010,45110,23210,1709,8489,8618,1428,0947,8717,5827,4877,538
  Current Assets12.0%7,4556,6585,1874,2973,3502,3361,9942,0782,1512,0092,2062,2272,2922,1552,2251,9702,0371,9871,9982,0602,283
    Cash Equivalents0.8%1,6001,5871,4991,383931463439595824570747702737553613318398465555641908
  Inventory15.0%3,6593,1812,0761,6141,2161,014799746733686750828851854769802814756701727666
  Net PPE6.8%7,8557,3536,9636,4256,2086,0295,9105,6555,5115,3905,3555,2435,1365,0264,9093,5243,3913,1703,0212,8252,670
  Goodwill0.0%1,6351,6341,6181,4681,5431,5761,5981,6231,6411,6291,6661,6031,5711,5591,5791,5341,5661,5611,5671,5911,586
  Current Liabilities22.4%4,2923,5052,7412,4881,7822,1031,8741,5919859531,8021,6131,4211,1931,4091,4211,4001,2781,1831,1271,042
    LT Debt, Current188.3%6.002.002.002512515043901.001.001.0080560440636.00187540491426307286209
    LT Debt, Non Current8.5%3,5093,2333,2153,1193,2061,9862,0042,0212,0442,0302,7672,9413,1323,1052,8631,3821,3981,3941,3981,4121,407
Shareholder's Equity3.8%9,8159,4597,9836,7336,3016,0355,8065,8956,3665,9434,4694,3254,2064,0424,0944,0083,9743,8643,7593,6863,837
  Retained Earnings8.9%7,3966,7935,6014,5153,6643,3043,0973,1463,5843,2053,1553,1123,0543,0102,9432,8922,7762,6612,5662,4792,385
  Additional Paid-In Capital0.1%2,9362,9322,9412,9342,9272,9152,9202,9132,9082,8901,4381,4111,4001,3941,3831,3791,3731,3681,3691,3631,610
Accumulated Depreciation2.7%2,5422,4772,3912,2892,2572,2102,1652,1282,0862,0432,0732,0422,0031,9481,9081,8821,8581,8131,7781,7461,706
Shares Outstanding0.0%117117117117117117117117117113107106106106106106106106106107110
Minority Interest10.7%273246208232216208180201200196200201182164161172174192174157144
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations9.1%2,6422,4231,90880919.00392344828977802799835728820719515522480546606582
  Share Based Compensation-4.1%35.0037.0030.0030.0027.0022.0020.0022.0021.0023.0023.0020.0019.0017.0020.0019.0017.0018.0015.0016.0018.00
Cashflow From Investing-13.9%-1,975-1,733-1,422-1,121-1,064-719-666-578-525-803-863-1,707-1,697-1,691-1,663-827-836-378-303-209-103
Cashflow From Financing-154.5%-2374366121,2201,22125150.00-360-392-17.001771,2671,3561,0181,04342.00-167-272-786-781-561
  Dividend Payments0.4%186185184184183182178173169164162160158156152149146145145144143
  Buy Backs-----------------500-500500250

ALB Income Statement

2023-06-30
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Net sales$ 2,370,190$ 1,479,593$ 4,950,442$ 2,607,321
Cost of goods sold1,811,703899,1693,115,4151,577,867
Gross profit558,487580,4241,835,0271,029,454
Selling, general and administrative expenses397,070128,942551,376241,510
Research and development expenses21,41917,38641,89033,469
(Gain) loss on sale of business/interest in properties0008,400
Operating profit139,998434,0961,241,761746,075
Interest and financing expenses(25,577)(41,409)(52,354)(69,243)
Other income, net53,9548,767136,44624,263
Income before income taxes and equity in net income of unconsolidated investments168,375401,4541,325,853701,095
Income tax expense42,98789,018319,950169,548
Income before equity in net income of unconsolidated investments125,388312,4361,005,903531,547
Equity in net income of unconsolidated investments (net of tax)551,051128,156947,239190,592
Net income676,439440,5921,953,142722,139
Net income attributable to noncontrolling interests(26,396)(33,819)(64,519)(61,983)
Net income attributable to Albemarle Corporation$ 650,043$ 406,773$ 1,888,623$ 660,156
Basic earnings per share (in dollars per share)$ 5.54$ 3.47$ 16.10$ 5.64
Diluted earnings per share (in dollars per share)$ 5.52$ 3.46$ 16.03$ 5.61
Weighted-average common shares outstanding - basic (in shares)117,332117,116117,282117,091
Weighted-average common shares outstanding - diluted (in shares)117,769117,724117,805117,689

ALB Balance Sheet

2023-06-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 1,599,738$ 1,499,142
Trade accounts receivable, less allowance for doubtful accounts (2023 – $3,008; 2022 – $2,534)1,344,2781,190,970
Other accounts receivable426,780185,819
Inventories3,658,6232,076,031
Other current assets425,358234,955
Total current assets7,454,7775,186,917
Property, plant and equipment, at cost10,396,9659,354,330
Less accumulated depreciation and amortization2,542,4242,391,333
Net property, plant and equipment7,854,5416,962,997
Investments1,621,4241,150,553
Other assets269,694250,558
Goodwill1,634,8231,617,627
Other intangibles, net of amortization274,409287,870
Total assets19,109,66815,456,522
Current liabilities:  
Accrued expenses672,807505,894
Current portion of long-term debt6,2472,128
Dividends payable46,65446,116
Income taxes payable513,339134,876
Total current liabilities4,291,5132,741,015
Long-term debt3,509,2893,214,972
Postretirement benefits32,79232,751
Pension benefits159,131159,571
Other noncurrent liabilities700,825636,596
Deferred income taxes328,078480,770
Commitments and contingencies (Note 9)
Albemarle Corporation shareholders’ equity:  
Common stock, $.01 par value, issued and outstanding – 117,340 in 2023 and 117,168 in 20221,1741,172
Additional paid-in capital2,936,0362,940,840
Accumulated other comprehensive loss(517,946)(560,662)
Retained earnings7,396,0455,601,277
Total Albemarle Corporation shareholders’ equity9,815,3097,982,627
Noncontrolling interests272,731208,220
Total equity10,088,0408,190,847
Total liabilities and equity19,109,66815,456,522
Nonrelated Party  
Current liabilities:  
Accounts payable1,960,0681,533,624
Related Party  
Current liabilities:  
Accounts payable$ 1,092,398$ 518,377
Jerry K. Masters
6000
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.